Cellular and longevity4 residues

Epitalon

Epithalon · AEDG

Epitalon and Epithalon are alternative names used for the AEDG tetrapeptide. This reference keeps one entry for both spellings and separates cell-culture telomere findings from longevity claims.

Reviewed September 2026

Residues
4. calculated: Count of residues in the stored canonical reference sequence; terminal groups are not extra residues.
Average mass
390.35 Da. calculated: Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded.
pI
3.67 (theoretical). calculated: Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation.

Primary structure

Sequence

N-terminusC-terminus

Peptide. Sequence describes the reference peptide, not a tested supplier lot.

Calculated properties

Calculated from the sequence
FormulaC14H22N4O9
Monoisotopic mass390.1387 Da
Extinction coefficient at 280 nmNone (no Tyr or Trp)
A280 at 1 mg/mLNot measurable
Residues4
Average mass390.35 Da
pI3.67 (theoretical)
Identity
AliasesEpithalon, AEDG
SequenceAEDG
Research areaCellular and longevity

Property basis and sources

These describe the reference compound or formulation, not identification or testing of the supplied lot.

Calculation scope: the stored canonical amino-acid sequence with free N- and C-termini, no other modifications or counterions. This specifies a reference form, not the chemical form or identity of a sold lot.

  • Residues: 4 (calculated). Count of residues in the stored canonical reference sequence; terminal groups are not extra residues. Residues source 1
  • Average mass: 390.35 Da (calculated). Calculated average neutral molecular mass of the unmodified free-terminal sequence, including one terminal water. Not monoisotopic mass; salts, counterions and solvates excluded. Average mass source 1 Average mass source 2 Average mass source 3
  • pI: 3.67 (theoretical) (calculated). Theoretical Bjellqvist/Biopython charge-model pI for the stated free-terminal, unmodified sequence (pH search 0–14). Model-dependent, not measured pI or formulation pH; not applicable to an unspecified amidated, acetylated or salt preparation. pI source 1 pI source 2

Residue composition

Unique residues
4
Most common
Alanine
Nonpolar residues
0
Other classified residues
4

Alanine is the most common residue (1). The calculated charge at pH 7 is net negative (-2.01).

Reference scope and linked records

Reference type: Peptide.

This is a research-reference entry, not a product certificate, treatment recommendation or administration guide. The sources below describe their own materials and methods. Catalogue identity, lot testing and clinical evidence are separate questions.

Catalogue context: Epithalon. The product retains its own name and specification; this link does not certify equivalence to published study material.

Related references

Sources and their scope

  1. Epithalon induces telomerase activity and telomere elongation in human somatic cells. Source for the chemistry or study context discussed above; not an Aminos lot certificate.
  2. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity. Source for the chemistry or study context discussed above; not an Aminos lot certificate.

Source check: 26 September 2026. This is an editorial source check, not a claim of independent clinical or laboratory review.

About Epitalon

Identity and context

The compound should not be confused with a heterogeneous pineal extract or with an unspecified anti-ageing blend. A short peptide identity is a chemical description, not evidence that the molecule slows ageing in people.

Reference classification

Peptide. The linked catalogue product is Epithalon. This reference does not independently authenticate the material supplied.

Storage and handling

Analytical specification

Keep the AEDG sequence and terminal chemistry on the specification. Do not substitute studies of an extract, or assume that identical marketing language identifies identical material.

Storage and experimental handling

Use the documented conditions for the actual chemical form and preparation. No universal storage temperature, expiry or solution shelf life is assigned here. Follow the lot documentation, safety data sheet and validated laboratory protocol; this page is not a reconstitution or administration guide.

Research evidence

Research evidence for this compound
AreaSummaryEvidence
What the source examinesThe 2003 paper reported telomerase activity and telomere elongation in human fetal fibroblast culture. A 2025 study examined normal and cancer cell lines, reporting different pathways associated with telomere extension, including alternative lengthening of telomeres in cancer cells.Source context
What cannot be inferredTelomere length is a laboratory endpoint, not a demonstrated increase in healthy human lifespan. Responses in cancer cells also make a simple narrative of universal benefit inappropriate. Neither paper tests the current Aminos lot.Evidence limits

References

Sources used for the data on this page, checked September 2026.

  1. Epithalon induces telomerase activity and telomere elongation in human somatic cellsPrimary source for the reference discussion; not lot-specific product evidence.
  2. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityPrimary source for the reference discussion; not lot-specific product evidence.

Reference information only. This page describes the chemistry and published research context of a laboratory compound. Nothing here is medical or dosing advice. Aminos compounds are for laboratory research use only and are not medicines.